Seeking Alpha
23 Sept 2026, 00:29 UTC · 1h ago
Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania Transcript
Verdict
Headline takes no side. We score RAPP +0.20 — slightly bullish.
- Expected · RAPP
+0.20slightly bullish
−1 bearish0bullish +1More positive than 52% of ticker scores this week
- Actual
